Imprimis Covenants. 6.2.1 Within thirty (30) days after the Effective Date, Imprimis shall transfer to Eton all tangible embodiments of the Technology in the possession and control of Imprimis. 6.2.2 Imprimis shall provide cooperation reasonably requested by Eton in connection with Eton’s efforts to establish, perfect, defend, or enforce its rights in or to the Assets (including without limitation the Assigned Patent Rights). Such cooperation shall include, without limitation, (a) executing such further assignments, transfers, licenses, releases and consents, and (b) providing such data and information, consulting with Eton and executing and delivering all such further documents and instruments, in each case as reasonably requested by Eton regarding the Assets (including without limitation the Assigned Patent Rights).
Appears in 4 contracts
Samples: Asset Purchase and License Agreement (Eton Pharmaceuticals, Inc.), Asset Purchase and License Agreement (Eton Pharmaceuticals, Inc.), Asset Purchase and License Agreement (Imprimis Pharmaceuticals, Inc.)
